![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
Sponsors and Collaborators: |
Hamilton Health Sciences Eli Lilly and Company |
---|---|
Information provided by: | McMaster University |
ClinicalTrials.gov Identifier: | NCT00182507 |
Trichotillomania (TTM) or hair-pulling has been considered as part of the obsessive compulsive disorder (OCD) spectrum, although treatment with OCD medications has largely been unsuccessful. Tics/Tourrettes’ Syndrome (TS) is a disorder, which appears to be related to TTM, but is treated with a different class of medications than used in OCD, namely antipsychotics such as olanzapine. This is a study of the safety and efficacy of olanzapine in the treatment of hair pulling.
Condition | Intervention | Phase |
---|---|---|
Trichotillomania |
Drug: Olanzapine |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | A 12-Week, Double-Blind Trial of Olanzapine and Placebo in the Treatment of Trichotillomania |
Estimated Enrollment: | 34 |
Study Start Date: | June 2000 |
Estimated Study Completion Date: | March 2006 |
Ages Eligible for Study: | 18 Years to 65 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Canada, Ontario | |
Hamilton Health Sciences, McMaster University Medical Centre | |
Hamilton, Ontario, Canada, L8N 3Z5 |
Principal Investigator: | Michael A Van Ameringen, MD, FRCPC | Hamilton Health Science, McMaster Univeristy Medical Centre |
Study ID Numbers: | 00-167 |
Study First Received: | September 14, 2005 |
Last Updated: | September 8, 2006 |
ClinicalTrials.gov Identifier: | NCT00182507 History of Changes |
Health Authority: | Canada: Health Canada |
Neurotransmitter Agents Tranquilizing Agents Olanzapine Psychotropic Drugs Central Nervous System Depressants Antiemetics Trichotillomania |
Antipsychotic Agents Serotonin Uptake Inhibitors Serotonin Impulse Control Disorders Mental Disorders Peripheral Nervous System Agents |
Neurotransmitter Agents Neurotransmitter Uptake Inhibitors Tranquilizing Agents Molecular Mechanisms of Pharmacological Action Physiological Effects of Drugs Gastrointestinal Agents Olanzapine Psychotropic Drugs Antiemetics Central Nervous System Depressants Trichotillomania |
Antipsychotic Agents Serotonin Uptake Inhibitors Pharmacologic Actions Impulse Control Disorders Serotonin Agents Autonomic Agents Mental Disorders Therapeutic Uses Peripheral Nervous System Agents Central Nervous System Agents |